Part 2: The Buyer Your Hospital Wants vs. The Buyer Your Hospital Needs

When a health system decides to sell its SNF, price is rarely the starting point for the decision and rarely dominates the early conversation. In our experience advising on hospital SNF divestitures, the concerns that come up first are clinical and operational: will the new operator keep accepting our discharges? Will they continue caring for our Medicaid-dependent and charity patients? Can they handle the acuity that comes off our floors? The financial case for selling, which we covered in depth in Part 1 of this series, is clear enough that it does not need to be the focus here. What health systems struggle with is trust. They know what they want from a buyer. What they do not always have is a structured way to evaluate whether a buyer can deliver it.

That is the problem this article is about.

What Health Systems Are Actually Protecting

The hesitation most health systems feel about divesting their SNF is not financial. It is relational, and it runs deeper than most advisors acknowledge.

The SNF has been a downstream destination for patients coming directly off their floors. It has accepted admissions that other operators in the market turned away. It has carried a Medicaid and long-term care census that reflects the health system’s broader community obligation. And it has employed hundreds of staff members, many of them long-tenured, whose relationships with residents and with the surrounding community represent a responsibility that does not simply transfer with the deed.

When health systems describe what they need from a buyer, the list is consistent and specific.

1. They want an operator who will continue accepting the acuity that comes off their floors, not just the straightforward cases.
2. They want someone who can grow the Medicare short-stay rehab census and sustain the long-term Medicaid population rather than quietly shifting the payer mix toward higher-margin admissions over time.
3. They want a transition that is stable for residents who have lived in that facility for years and for staff who have worked there just as long.
4. And they want a long-term partner whose commitment to the community is demonstrated by their operating history, not asserted in a letter of intent.

When a health system puts that facility into a sale process, what they are really asking is: who can we hand this to and still feel responsible for what happens to those patients, those employees, and those communities? That is not a question a financial package answers. And it is not one that gets resolved by taking the highest offer.

The right process is built around answering that question with evidence.

The Gap Between What Buyers Promise and What They Can Prove

Most operators who submit an offer on a hospital SNF will tell the seller what they want to hear. They will commit to accepting complex discharges. They will express deep respect for the facility’s Medicaid mission. They will present polished materials and experienced leadership teams. That is the nature of a competitive sale process, and it is not unique to this asset class.

The gap that matters is between what an operator promises in a presentation and what their operating history shows. A buyer can commit in writing to maintaining high acuity admissions. That commitment means very little if their existing portfolio shows a pattern of declining complex cases, thin RN staffing, and rising readmission rates. The history is the best indicator. The presentation is just the conversation.

Building a process that surfaces that history is the work.

A Third Party Now Has a Say

The conversation about buyer quality in a hospital SNF divestiture used to involve two parties: the seller and the prospective operator. The health system set the criteria. An advisor built the process to evaluate against them. And which buyer was selected was the health system’s decision to make.

That is no longer the complete picture.

States are entering these transactions as active participants with real authority to halt or unwind a deal. Not just as administrative processors of a change-of-ownership application, but as parties evaluating buyer quality on their own terms, against their own standards, with the power to say no.

Virginia’s HB 717, passed unanimously through both chambers of the General Assembly and effective July 1, 2026, creates one of the most demanding change-of-operator licensing requirements in the country. Before taking over daily operations of a Virginia nursing home, an incoming operator must apply for and receive a license from the Commissioner of Health. That application requires disclosure of all owners with a five percent or greater ownership interest, documentation of at least five years of relevant operational experience, written plans for risk management, quality assurance, staffing, and insurance, and a full accounting of any prior license suspension, denial, revocation, or bankruptcy across the buyer’s portfolio, anywhere in the country, going back five years. The buyer must also post a bond of $10,000 multiplied by the number of licensed beds, held for five years following close. Operators who proceed without a license face civil penalties of $2,000 per day.

New York has operated under a similar framework for years through its Public Health and Health Planning Council, which applies a seven-year lookback period to the quality of every facility in a proposed buyer’s existing portfolio. Applications from operators affiliated with nursing homes carrying poor star ratings or patterns of serious deficiencies can be denied outright. The state recently established a formal committee specifically to strengthen its character and competence review process for nursing home buyers, with authority to impose conditions on approvals or appoint an external reviewer at the applicant’s expense.

The direction of travel is clear. States are no longer willing to defer buyer evaluation entirely to the parties in the transaction. They have decided that the quality of who receives a nursing home license is a public interest question, not just a commercial one, and they are building the legal frameworks to act on that conclusion.

What This Means for the Sale Process

If a state can veto a transaction on quality grounds, a seller who selects a buyer without doing serious quality work has created a problem that only reveals itself after the deal is signed. The transaction goes under contract. The state reviews the incoming operator. The buyer does not clear the review. The deal unravels.

For a health system managing a board-approved process, community expectations, and a building full of patients and staff who need certainty about what comes next, that is not a recoverable situation.

The practical answer is that a seller needs to know, before a buyer is selected, whether that buyer will clear state review. That requires a vetting process that evaluates the criteria the state will apply — operating history, regulatory track record, staffing depth, quality across the full portfolio — early enough in the process that the answer can still shape the outcome.

The scorecard Senwell uses addresses this directly. By the time a buyer is selected through that process, they have typically already cleared the bar a state would apply — not as a side effect, but because that bar was built into how we evaluated them from the beginning.

Transactions that skip that work upfront find out what the state will say after it is already too late to choose someone else.

What the Scorecard Is Actually Measuring

In every hospital SNF divestiture we advise on, we evaluate prospective buyers against a detailed scorecard before price becomes the primary driver of selection. The metrics are drawn and structured directly around the health system’s priorities.

We look at CMS star ratings across the buyer’s full portfolio, not just their strongest building. We look at RN hours per resident day and total nurse staffing levels, because staffing is what determines whether an operator can accept the acuity the hospital sends. We look at readmission rates and discharge-to-community rates, because those numbers reveal whether an operator is managing the clinical handoff well or just turning patients over. We look at nursing, RN, and administrator turnover separately, because each one reflects something different about how a building is run day to day.

We look at survey history with specific attention to Special Focus Facility designations and SFF-candidate flags across every state the operator works in, because a health system’s board will ask about regulatory history and they should. We look at how the operator has managed Medicaid-heavy portfolios in comparable markets, because a commitment to charity care made during a presentation has to be backed by a track record of running that census.

And we look at whether the operator has meaningful experience in the state and market where the facility sits, because new market entry during an already complex transition carries real risk.

We also assess the operator’s information technology capability. The transition from a hospital clinical platform to a post-acute operating system is one of the most demanding operational aspects of a hospital SNF acquisition. It requires dedicated IT resources, experienced project management, and a team that has executed this kind of migration before. An operator running lean IT infrastructure is not positioned to manage that transition without introducing real operational risk. We evaluate the depth of the buyer’s IT function, their system transition history, whether they have the internal capacity to execute a platform migration without disrupting care delivery or compromising data continuity, and whether the leadership team has actually executed this kind of transition before — because IT capability on paper is not the same as organizational experience under a live deal timeline.

None of this is visible on the first page of a LOI. All of it is visible if you build a process designed to find it.

The Acuity Test

The patients who discharge from a hospital into an affiliated SNF are not the same population as the average freestanding SNF census. They arrive post-surgical, medically complex, often with short, expected stays and high clinical demands. The care model has to match.

The question we ask every operator in the presentation process is specific: walk us through how you manage high-acuity short-stay admissions in your current portfolio. The answer tells us more about fit than anything in the financial model.

In hospital SNF divestitures we advise on, a large initial field of interested buyers is systematically narrowed through the scorecard process, then through a structured presentation phase where a qualified group presents directly to the health system’s leadership team. Not just on their financial assumptions, but on their operating philosophy, their staffing approach, and their specific plan for managing the facility or portfolio of facilities. From that group, a final shortlist is evaluated before a selection is made. The operator who wins is sometimes not the highest offer. They typically win because they give the most credible, evidence-backed answer to the question the health system cares about: are you built to take care of our patients after we leave?

What Participation in the Post-Acute Network Actually Means

Most buyers expect that continuing to receive hospital referrals after close will require some kind of formal agreement. Few of them understand how demanding that agreement is until they are already under LOI.

At large health systems with mature post-acute programs, participation is a detailed set of contractual obligations: 24-hour, 7-day admission acceptance for patients within the operator’s clinical capabilities; specific average length of stay benchmarks for Medicare and Medicare Advantage patients; readmission rate thresholds tied to nationally recognized methodologies; integration with the hospital’s electronic health record platform; and regular clinical reporting back to the health system on all attributed patients.

An operator who cannot meet these obligations will either lose the referral stream that makes the acquisition viable or compromise their operations trying to meet standards they were never built for. The right buyer has done this before and can show it.

How the Process Produces the Right Answer

The goal of a well-structured hospital SNF sale process is to find the qualified buyer who can close, transition without disruption for patients and staff, maintain the clinical standards the health system’s reputation depends on, and still be a reliable partner years after close. Price matters within that qualified pool. It is not the filter that creates it.

Health systems that run a process designed around their actual priorities — clinical track record, acuity capability, Medicaid commitment, post-acute network alignment, and transition experience — consistently end up with buyers who deliver on what was promised. Health systems that run a process without that structure tend to find out what was missing during the first year of operations.

The questions a health system cares most about at the start of a sale process are the same questions a well-run divestiture answers before anyone signs anything.